We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRosiglitazone increased heart failure but did not differ from metformin plus sulfonylurea for other CV outcomes at interim analysis.AuthorsHlatky MA; Bravata DMPublicationACP journal club, 2007, Vol 147, Issue 3, p67ISSN1056-8751Publication typearticle